Vedolizumab for stricturing Crohn's disease of the terminal ileum - an international multicenter cohort study.

El Ouali S, Baker ME, Lu C, Medellin A, Bruining DH, Fletcher JG, Inoue A, Regueiro M, Ottichilo RK, Schoenoff S, Rosentreter R, Bena J, Qazi T, Holubar SD, Gauriloff S, Gandhi NS, Falloon K, Sleiman J, Cohen BL, Goren I, Balci N, Rieder F, Stenosis Therapy and Anti-Fibrotic Research (STAR) Consortium

Open source

DOI: 10.1186/s12876-026-04815-4
Published: 2026 May 20
Container: BMC gastroenterology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1186/s12876-026-04815-4,
  title = {Vedolizumab for stricturing Crohn's disease of the terminal ileum - an international multicenter cohort study.},
  author = {El Ouali S and Baker ME and Lu C and Medellin A and Bruining DH and Fletcher JG and Inoue A and Regueiro M and Ottichilo RK and Schoenoff S and Rosentreter R and Bena J and Qazi T and Holubar SD and Gauriloff S and Gandhi NS and Falloon K and Sleiman J and Cohen BL and Goren I and Balci N and Rieder F and Stenosis Therapy and Anti-Fibrotic Research (STAR) Consortium},
  year = {2026},
  journal = {BMC gastroenterology},
  doi = {10.1186/s12876-026-04815-4},
  url = {https://doi.org/10.1186/s12876-026-04815-4}
}

RIS

TY  - JOUR
TI  - Vedolizumab for stricturing Crohn's disease of the terminal ileum - an international multicenter cohort study.
AU  - El Ouali S
AU  - Baker ME
AU  - Lu C
AU  - Medellin A
AU  - Bruining DH
AU  - Fletcher JG
AU  - Inoue A
AU  - Regueiro M
AU  - Ottichilo RK
AU  - Schoenoff S
AU  - Rosentreter R
AU  - Bena J
AU  - Qazi T
AU  - Holubar SD
AU  - Gauriloff S
AU  - Gandhi NS
AU  - Falloon K
AU  - Sleiman J
AU  - Cohen BL
AU  - Goren I
AU  - Balci N
AU  - Rieder F
AU  - Stenosis Therapy and Anti-Fibrotic Research (STAR) Consortium
PY  - 2026
JO  - BMC gastroenterology
DO  - 10.1186/s12876-026-04815-4
UR  - https://doi.org/10.1186/s12876-026-04815-4
ER  -

APA

S, E. O., ME, B., C, L., A, M., DH, B., JG, F., A, I., M, R., RK, O., S, S., R, R., J, B., T, Q., SD, H., S, G., NS, G., K, F., J, S., BL, C., I, G., N, B., F, R., & Consortium, S. T. A. A. R. (. (2026). Vedolizumab for stricturing Crohn's disease of the terminal ileum - an international multicenter cohort study.. BMC gastroenterology. https://doi.org/10.1186/s12876-026-04815-4

Source records

pubmed · retrieved 2026-09-25T23:32:52.713Z